Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Thomas Guzzo MD, MPH

Thomas J. Guzzo MD, MPH

Chief of Urology and Associate Program Director, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania

Dr. Guzzo is Chief of Urology and Associate Program Director at the University of Pennsylvania. He is a graduate of Temple University School of Medicine. He completed his general surgery internship and urology residency at the Hospital of the University of Pennsylvania. Dr. Guzzo completed a fellowship at the James Buchanan Brady Urological Institute of the Johns Hopkins Hospital in urologic oncology. During his fellowship he also earned a Masters in Public Health from the Johns Hopkins Bloomberg School of Public Health. He is extensively trained in the treatment of all aspects of urologic malignancies including open, laparoscopic, endoscopic and robotic surgical treatment for such malignancies.

Dr. Guzzo’s clinical areas of expertise include the surgical treatment of prostate, bladder, kidney and testicular cancer. He has one of the largest urologic oncology practices in the region and specializes in open, endoscopic and minimally invasive surgical procedures. Additionally, he is a member of the Penn Academy of master clinicians.

Dr. Guzzo also maintains a productive urologic oncology research program. He is a Prostate Cancer Foundation young investigator award recipient. He is the director of the urologic oncology research laboratory at the University of Pennsylvania. He has published over 120 peer-reviewed manuscripts, over a dozen book chapters and is the editor of two text books in urology.

Disclosures

No disclosures to report.

Recent Contributions to PracticeUpdate:

  1. 68Ga-PSMA PET SUVmax for Predicting Gleason Pattern 4 and Pathological Upgrading in Intermediate-Risk Prostate Cancer
  2. 2021 Top Story in Urology: Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer
  3. 18F-Fluciclovine PET/CT vs Conventional Imaging Alone to Guide Postprostatectomy Salvage Radiotherapy
  4. ASCO GU 2021: Recommendations From Dr. Thomas Guzzo
  5. 2020 Top Stories in Urology: 2-Year Follow-Up Data From KEYNOTE-057
  6. ASCO 2020: Abstract Recommendations From Dr. Tom Guzzo for Genitourinary Cancer
  7. ASCO 2020: Abstract Recommendations From Dr. Thomas Guzzo for Genitourinary Cancer
  8. Chemotherapy After Prostatectomy for High-Risk Prostate Carcinoma
  9. Radical Prostatectomy or Radiotherapy for High- and Very High–Risk Prostate Cancer
  10. Survival Outcomes of Radical Prostatectomy vs EBRT in Prostate Cancer Patients With Gleason Score 9–10 at Biopsy

Most Read This Week

Recently Updated